| Name | Title | Contact Details |
|---|
Marligen Biosciences, Inc. is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cerus Corp. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Turnstone Biologics is driven by science and innovation, with experienced leadership and world-renowned scientific founders in the field of oncolytics and immunotherapies
Triad Technologies, Llc is a Englewood, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Genocea is harnessing the power of T cell immunity to develop the next generation of vaccines and immunotherapies. T cells are increasingly recognized as a critical element of protective immune responses to a wide range of diseases, but are difficult to target using traditional discovery methods. Genocea is able to identify protective T cell antigens in humans using ATLAS(TM), its proprietary technology platform, potentially enabling vaccines and immunotherapies to address critical patient needs. Genocea's pipeline of novel clinical stage T cell-enabled product candidates includes GEN-003 for HSV-2 therapy, GEN-004 to prevent infections caused by pneumococcus, and earlier-stage programs in chlamydia, HSV-2 prophylaxis, malaria and cancer immunotherapy.